CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $42,974 | -30.1% | 10,232 | 0.0% | 0.00% | – |
Q4 2022 | $61,494 | +6.0% | 10,232 | +2.3% | 0.00% | – |
Q3 2022 | $58,000 | -3.3% | 10,000 | -1.0% | 0.00% | – |
Q2 2022 | $60,000 | +27.7% | 10,100 | +1.0% | 0.00% | – |
Q1 2022 | $47,000 | +88.0% | 10,000 | 0.0% | 0.00% | – |
Q4 2021 | $25,000 | +1150.0% | 10,000 | +900.0% | 0.00% | – |
Q4 2019 | $2,000 | – | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 1,000 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
FNY Investment Advisers, LLC | 20 | $0 | 0.00% |